SCHEMBL3560635

SCHEMBL3560635

Cc1ccc(S(=O)(=O)n2c(C)c(OCCN(C)C)c3ccc(Cl)cc32)c(Br)c1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 5/20 0.36
ACLY P53396 3/20 0.36
HTR6 P50406 3/20 0.36
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GAA P10253 2/20 0.34
MAPK1 P28482 1/20 0.34
TSHR P16473 2/20 0.34
HTT P42858 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
MAPT P10636 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3559180 0.92 ACLY (0.42) CYP1A2CYP2D6CYP2C19KDM4EACLY
SCHEMBL3562400 0.91 HTR6 (0.41) ACLYHTR6
SCHEMBL3561949 0.89 HTR6 (0.44) KDM4EACLYHTR6ALDH1A1SMN1; SMN2
SCHEMBL3565645 0.87 ACLY (0.41) CYP1A2CYP2D6CYP2C19KDM4EACLY
SCHEMBL3560725 0.87 HTR6 (0.40) CYP1A2CYP2D6CYP2C19KDM4EHTR6
SCHEMBL3553798 0.85 HTR6 (0.42) KDM4EHTR6ALDH1A1HTTLMNA
SCHEMBL3562850 0.85 CYP1A2 (0.37) CYP1A2CYP2D6CYP2C19KDM4EALDH1A1
SCHEMBL3557164 0.84 CYP1A2 (0.38) CYP1A2CYP2D6CYP2C19KDM4EACLY
SCHEMBL3567118 0.84 KDM4E (0.38) CYP1A2CYP2D6CYP2C19KDM4EACLY
SCHEMBL3557970 0.84 HTR6 (0.46) ACLYHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP claimed
US-7507835-B2 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LTD. (IN) 2009-03-24 US claimed
US-20060173193-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2006-08-03 US claimed
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed
US-7507835-B2 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LTD. (IN) 2009-03-24 US disclosed
US-20060173193-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2006-08-03 US disclosed
EP-1567492-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES Suven Life Sciences Limited (IN) 2005-08-31 EP disclosed
WO-2004048328-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT CYP1A2 52/4885CYP2D6 24/4885CYP2C19 37/4885
US-20060173193-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT CYP1A2 52/4885CYP2D6 24/4885CYP2C19 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.